Targeting the Human T-Cell Inducible COStimulator Molecule with a Monoclonal Antibody Prevents Graft-vs-Host Disease and Preserves Graft vs Leukemia in a Xenograft Murine Model

BACKGROUND: Graft-vs-host disease (GVHD) is a major complication of allogenic bone marrow transplantation (BMT). Targeting costimulatory molecules with antagonist antibodies could dampen the excessive immune response that occurs, while preserving the beneficial graft vs leukemia (GVL) of the allogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Burlion, Aude, Brunel, Simon, Petit, Nicolas Y., Olive, Daniel, Marodon, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491549/
https://www.ncbi.nlm.nih.gov/pubmed/28713380
http://dx.doi.org/10.3389/fimmu.2017.00756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491549/
https://www.ncbi.nlm.nih.gov/pubmed/28713380
http://dx.doi.org/10.3389/fimmu.2017.00756

Ejemplares similares